Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Revive Therapeutics Ltd. (V.RVV) had Cash Flow from Financial Activities of 20.46M for the most recently reported fiscal year, ending 2021-06-30.
| Income Statement Financials | |
-- |
|
-15.69M |
|
-- |
|
-- |
|
-- |
|
-14.48M |
|
-- |
|
-15.69M |
|
-15.83M |
|
-15.69M |
|
-15.69M |
|
-15.69M |
|
-15.83M |
|
-14.48M |
|
-14.48M |
|
267.49M |
|
267.49M |
|
-0.06 |
|
-0.06 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
23.24M |
|
-- |
|
-- |
|
-- |
|
0.78M |
|
22.46M |
|
12.71M |
|
22.46M |
|
317.96M |
|
| Cash Flow Statement Financials | |
-6.48M |
|
-2.12M |
|
|
Cash Flow from Financial Activities |
20.46M |
1.08M |
|
12.94M |
|
11.87M |
|
6.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.11 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-69.84% |
|
-123.38% |
|
-67.50% |
|
-69.06% |
|
0.09 |
|
-0.02 |
|
-0.02 |
|